Biomarker | With diabetes | Without diabetes | p Values |
Inflammatory markers (pg/ml)* | |||
TNF | 4.77 (2.12) | 4.73 (2.65) | 0.51 |
IL-6 | 8.67 (6.83) | 7.41 (5.74) | 0.03 |
IL-10 | 1 (18.45) | 1.24 (11.92) | 0.6 |
Coagulation markers* | |||
Factor IX activity (%) | 111.02 (1.30) | 119.14 (1.25) | 0.1 |
Antithrombin (mg/ml) | 91.77 (1.04) | 91.50 (1.04) | 0.87 |
TAT complexes (μg/ml) | 4.25 (3.70) | 3.58 (2.49) | 0.25 |
Fibrinolysis markers (ng/ml)* | |||
D-dimer | 623.79 (3.26) | 600.86 (2.92) | 0.67 |
PAI-1 | 3.54 (4.27) | 3.72 (4.63) | 0.62 |
↵* Inflammatory, coagulation and fibrinolysis markers were available at hospital discharge in 1739, 892 and 892 subjects, respectively.
IL, interleukin; PAI, plasminogen activator inhibitor; TAT, thrombin–antithrombin; TNF, tumour necrosis factor.